Report Detail
Global Passive Transdermal Drug Delivery Market Insights, Forecast to 2025
- RnM2848997 |
- 31 January, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Other
The global Passive Transdermal Drug Delivery market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Passive Transdermal Drug Delivery market based on company, product type, end user and key regions.
This report studies the global market size of Passive Transdermal Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Passive Transdermal Drug Delivery in these regions.
This research report categorizes the global Passive Transdermal Drug Delivery market by top players/brands, region, type and end user. This report also studies the global Passive Transdermal Drug Delivery market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Market size by Product
Microfluidics
Smart Pill Technology (SPT)
Market size by End User
Clinic
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Passive Transdermal Drug Delivery market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Passive Transdermal Drug Delivery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Passive Transdermal Drug Delivery companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Passive Transdermal Drug Delivery submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Passive Transdermal Drug Delivery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Passive Transdermal Drug Delivery market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Passive Transdermal Drug Delivery Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by Product
- 1.4.2 Microfluidics
- 1.4.3 Smart Pill Technology (SPT)
- 1.5 Market by End User
- 1.5.1 Global Passive Transdermal Drug Delivery Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Passive Transdermal Drug Delivery Market Size
- 2.1.1 Global Passive Transdermal Drug Delivery Revenue 2014-2025
- 2.1.2 Global Passive Transdermal Drug Delivery Sales 2014-2025
- 2.2 Passive Transdermal Drug Delivery Growth Rate by Regions
- 2.2.1 Global Passive Transdermal Drug Delivery Sales by Regions
- 2.2.2 Global Passive Transdermal Drug Delivery Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Passive Transdermal Drug Delivery Sales by Manufacturers
- 3.1.1 Passive Transdermal Drug Delivery Sales by Manufacturers
- 3.1.2 Passive Transdermal Drug Delivery Sales Market Share by Manufacturers
- 3.1.3 Global Passive Transdermal Drug Delivery Market Concentration Ratio (CR5 and HHI)
- 3.2 Passive Transdermal Drug Delivery Revenue by Manufacturers
- 3.2.1 Passive Transdermal Drug Delivery Revenue by Manufacturers (2014-2019)
- 3.2.2 Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2014-2019)
- 3.3 Passive Transdermal Drug Delivery Price by Manufacturers
- 3.4 Passive Transdermal Drug Delivery Manufacturing Base Distribution, Product Types
- 3.4.1 Passive Transdermal Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Passive Transdermal Drug Delivery Product Type
- 3.4.3 Date of International Manufacturers Enter into Passive Transdermal Drug Delivery Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Passive Transdermal Drug Delivery Sales by Product
- 4.2 Global Passive Transdermal Drug Delivery Revenue by Product
- 4.3 Passive Transdermal Drug Delivery Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Passive Transdermal Drug Delivery Breakdown Data by End User
6 North America
- 6.1 North America Passive Transdermal Drug Delivery by Countries
- 6.1.1 North America Passive Transdermal Drug Delivery Sales by Countries
- 6.1.2 North America Passive Transdermal Drug Delivery Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Passive Transdermal Drug Delivery by Product
- 6.3 North America Passive Transdermal Drug Delivery by End User
7 Europe
- 7.1 Europe Passive Transdermal Drug Delivery by Countries
- 7.1.1 Europe Passive Transdermal Drug Delivery Sales by Countries
- 7.1.2 Europe Passive Transdermal Drug Delivery Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Passive Transdermal Drug Delivery by Product
- 7.3 Europe Passive Transdermal Drug Delivery by End User
8 Asia Pacific
- 8.1 Asia Pacific Passive Transdermal Drug Delivery by Countries
- 8.1.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Countries
- 8.1.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Passive Transdermal Drug Delivery by Product
- 8.3 Asia Pacific Passive Transdermal Drug Delivery by End User
9 Central & South America
- 9.1 Central & South America Passive Transdermal Drug Delivery by Countries
- 9.1.1 Central & South America Passive Transdermal Drug Delivery Sales by Countries
- 9.1.2 Central & South America Passive Transdermal Drug Delivery Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Passive Transdermal Drug Delivery by Product
- 9.3 Central & South America Passive Transdermal Drug Delivery by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Passive Transdermal Drug Delivery by Countries
- 10.1.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Countries
- 10.1.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Passive Transdermal Drug Delivery by Product
- 10.3 Middle East and Africa Passive Transdermal Drug Delivery by End User
11 Company Profiles
- 11.1 3M
- 11.1.1 3M Company Details
- 11.1.2 Company Business Overview
- 11.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 3M Passive Transdermal Drug Delivery Products Offered
- 11.1.5 3M Recent Development
- 11.2 Actavis, Inc.
- 11.2.1 Actavis, Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Products Offered
- 11.2.5 Actavis, Inc. Recent Development
- 11.3 Bayer AG
- 11.3.1 Bayer AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer AG Passive Transdermal Drug Delivery Products Offered
- 11.3.5 Bayer AG Recent Development
- 11.4 Boehringer Ingelheim GmbH
- 11.4.1 Boehringer Ingelheim GmbH Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Products Offered
- 11.4.5 Boehringer Ingelheim GmbH Recent Development
- 11.5 Corium International, Inc.
- 11.5.1 Corium International, Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Products Offered
- 11.5.5 Corium International, Inc. Recent Development
- 11.6 Echo Therapeutics, Inc.
- 11.6.1 Echo Therapeutics, Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Products Offered
- 11.6.5 Echo Therapeutics, Inc. Recent Development
- 11.7 GlaxoSmithKline plc
- 11.7.1 GlaxoSmithKline plc Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Products Offered
- 11.7.5 GlaxoSmithKline plc Recent Development
- 11.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
- 11.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Products Offered
- 11.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
- 11.9 Mylan N.V.
- 11.9.1 Mylan N.V. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Mylan N.V. Passive Transdermal Drug Delivery Products Offered
- 11.9.5 Mylan N.V. Recent Development
- 11.10 Novartis AG
- 11.10.1 Novartis AG Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis AG Passive Transdermal Drug Delivery Products Offered
- 11.10.5 Novartis AG Recent Development
- 11.11 Noven Pharmaceuticals, Inc.
- 11.12 Transdermal Corp.
12 Future Forecast
- 12.1 Passive Transdermal Drug Delivery Market Forecast by Regions
- 12.1.1 Global Passive Transdermal Drug Delivery Sales Forecast by Regions 2019-2025
- 12.1.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Regions 2019-2025
- 12.2 Passive Transdermal Drug Delivery Market Forecast by Product
- 12.2.1 Global Passive Transdermal Drug Delivery Sales Forecast by Product 2019-2025
- 12.2.2 Global Passive Transdermal Drug Delivery Revenue Forecast by Product 2019-2025
- 12.3 Passive Transdermal Drug Delivery Market Forecast by End User
- 12.4 North America Passive Transdermal Drug Delivery Forecast
- 12.5 Europe Passive Transdermal Drug Delivery Forecast
- 12.6 Asia Pacific Passive Transdermal Drug Delivery Forecast
- 12.7 Central & South America Passive Transdermal Drug Delivery Forecast
- 12.8 Middle East and Africa Passive Transdermal Drug Delivery Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Passive Transdermal Drug Delivery Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Passive Transdermal Drug Delivery . Industry analysis & Market Report on Passive Transdermal Drug Delivery is a syndicated market report, published as Global Passive Transdermal Drug Delivery Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Passive Transdermal Drug Delivery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
